Core Viewpoint - The company aims to enhance the efficiency of its raised funds by utilizing temporarily idle funds for cash management, ensuring safety and not affecting ongoing investment plans or normal operations [3][6]. Cash Management Overview - The amount used for cash management is RMB 5 million [5]. - The source of funds for this cash management is part of the temporarily idle funds raised from issuing convertible bonds [3][5]. - The cash management method involves a seven-day notice deposit with an annualized return rate of 0.65% [5][6]. - The cash management period is from June 30, 2025, to July 7, 2025, not exceeding 12 months [6]. Approval Process - The company held its fifth board meeting and supervisory board meeting on April 28, 2025, where it approved the use of up to RMB 400 million of temporarily idle funds for cash management, valid for 12 months from the approval date [5][6]. Impact on the Company - The use of idle funds for cash management will not affect the normal operation of investment projects and aims to improve fund utilization efficiency, thereby providing better returns for shareholders [6][7].

现将公司根据上述决议使用部分暂时闲置募集资金进行现金管理的实施进展 情况公告如下： 证券代码：002812 股票简称：恩捷股份 公告编号：2025-101 债券代码：128095 债券简称：恩捷转债 云南恩捷新材料股份有限公司 本公司及全体董事保证本公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 云南恩捷新材料股份有限公司（以下简称"公司"）于 2025 年 6 月 16 日召开 第五届董事会第四十四次会议，审议通过了《关于使用部分闲置募集资金进行现 金管理的议案》，同意公司在确保不影响募集资金投资计划正常进行的情况下， 使用不超过人民币 30,000.00 万元的 2021 年度非公开发行 A 股股票的闲置募集资 金进行现金管理，适时购买安全性高、流动性好、保本型具有合法经营资格的金 融机构销售的理财类产品或存款类产品。现金管理期限自本事项经董事会审议通 过之日起不超过 12 个月。在上述额度和期限内资金可以滚动使用，同时授权公 司董事长或其授权代表行使该项投资决策权并签署相关合同。具体内容详见公司 于 2025 年 6 月 17 日在《证券时报》《中国证券报》《证券日报》《上海证券报》 ...

Core Viewpoint - The company has announced an extension of the cash management plan for idle raised funds from its non-public issuance of A-shares and public issuance of convertible bonds, allowing for a maximum of RMB 17 billion and RMB 19 billion respectively for cash management [1][2][4] Summary by Sections 1. Basic Situation of Raised Funds - The total amount raised from the non-public issuance of A-shares is RMB 12.782 billion, with a net amount of RMB 12.776 billion after deducting issuance costs, used for introducing 31 aircraft and repaying company loans [2][3] - As of March 31, 2025, RMB 12.594 billion has been invested from the non-public issuance, generating RMB 0.457 billion in interest and cash management income, leaving a remaining amount of RMB 0.639 billion [3] - The total amount raised from the public issuance of convertible bonds is RMB 16 billion, with a net amount of RMB 15.980 billion after costs, used for aircraft purchases and working capital [3] - As of March 31, 2025, RMB 15.509 billion has been invested from the public issuance, generating RMB 0.710 billion in interest and cash management income, leaving a remaining amount of RMB 1.181 billion [3] 2. Specifics of Cash Management Extension - The maximum amount for cash management from the non-public issuance is set at RMB 7 billion, while for the public issuance, it is RMB 12 billion, with a rolling management approach [4][5] - The extension period for cash management is 12 months from the end of the previous authorization, specifically from June 23, 2025, to June 22, 2026, for non-public issuance and from October 23, 2025, to October 22, 2026, for public issuance [4][5] - The cash management products will include seven-day notice deposits and transferable large-denomination certificates of deposit [4] 3. Impact on the Company - The cash management of idle raised funds is conducted in compliance with national laws and regulations, ensuring no impact on the normal investment progress of raised funds [5][6] - This approach aims to enhance the efficiency of fund utilization and increase returns for the company and its shareholders [5][6] 4. Risk Control Measures - Strict management of raised funds will be implemented, ensuring that only idle funds are used for cash management and that no non-raised funds are mixed [6] - Continuous monitoring of deposit products will be conducted to ensure liquidity and safety of funds [6] - The sponsor institution will supervise the use of funds and the board and supervisory board have the right to inspect the fund usage [6]

证券代码：600713 证券简称：南京医药 编号：ls2025-070 公司于 2025 年 4 月 21 日赎回部分上述理财产品，收回本金 300 万元，并获 得理财收益 6.9808 万元，本金及收益已归还至募集资金专用账户中，详情请见 公司于 2025 年 4 月 23 日对外披露的编号为 ls2025-051 之《南京医药股份有限公 司关于公司及子公司使用部分暂时闲置募集资金进行现金管理提前赎回的公告》。 现因募集资金置换及募集资金项目资金使用需要，公司于 2025 年 5 月 20 日赎回部分上述理财产品，收回本金 5,300 万元，并获得理财收益 8 万元，本金 及收益已归还至募集资金专用账户中。截至本公告披露之日，共赎回上述理财产 品本金 5,800 万元，共获得理财收益 14.9874 万元。 二、公司最近十二个月使用募集资金进行现金管理的情况 债券代码：110098 债券简称：南药转债 南京医药股份有限公司关于公司及子公司 使用部分暂时闲置募集资金进行现金管理提前赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承 ...

| 证券代码：600548 | 股票简称：深高速 | | | 公告编号：临 | 2025-058 | | --- | --- | --- | --- | --- | --- | | 债券代码：188451 | 债券简称：21 | 深高 | 01 | | | | 债券代码：185300 | 债券简称：22 | 深高 | 01 | | | | 债券代码：240067 | 债券简称：G23 | 深高 | 1 | | | | 债券代码：241018 | 债券简称：24 | 深高 | 01 | | | | 债券代码：241019 | 债券简称：24 | 深高 | 02 | | | | 债券代码：242050 | 债券简称：24 | 深高 | 03 | | | | 债券代码：242539 | 债券简称：25 | 深高 | 01 | | | | 债券代码：242780 | 债券简称：25 | 深高 | Y1 | | | | 债券代码：242781 | 债券简称：25 | 深高 | Y2 | | | | 债券代码：242972 | 债券简称：25 | 深高 | Y3 | | | | 债券代码：242973 | 债券简称：25 ...